Biomarin Pharmaceutical shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 1.6M | 0.95 |
| 2025-06-30 | $1.5M | 1.6M | 0.94 |
| 2025-03-31 | $1.5M | 1.6M | 0.94 |
| 2024-12-31 | $2.5M | 2.7M | 0.93 |
| 2024-09-30 | $2.6M | 2.7M | 0.95 |
| 2024-06-30 | $2.7M | 2.9M | 0.96 |
| 2024-03-31 | $125k | 126k | 0.99 |
| 2023-12-31 | $130k | 126k | 1.03 |
| 2023-09-30 | $993 | 1.0k | 0.99 |
| 2023-06-30 | $1.0k | 1.0k | 1.01 |
| 2021-12-31 | $309k | 299k | 1.03 |